CARGO Therapeutics, Inc. Common Stock
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRGX research report →
About the company
CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering innovative chimeric antigen receptor (CAR) T-cell therapies for patients battling cancer. Its primary therapeutic candidate is CRG-022, an autologous CD22 CAR T-cell product.
- CEO
- Anup Radhakrishnan
- IPO
- 2023
- Employees
- 167
- HQ
- San Mateo, DE, US
Price Chart
- Market Cap
- $216.19M
- P/E
- -1.18
- P/S
- 27.61
- P/B
- 0.91
- EV/EBITDA
- -1.09
- Div Yield
- 0.00%
- Gross Margin
- -40.29%
- Op Margin
- -2445.19%
- Net Margin
- -2297.19%
- ROE
- -61.29%
- ROIC
- -80.35%
- Revenue
- $0 · 0.00%
- Net Income
- $-167,502,000 · -70.66%
- EPS
- $-3.72 · -56.30%
- Op Income
- $-187,370,000
- FCF YoY
- -59.93%
- 52W High
- $25.45
- 52W Low
- $3.00
- 50D MA
- $4.45
- 200D MA
- $7.81
- Beta
- 0.29
- Avg Volume
- 1.68M
Get TickerSpark's AI analysis on CRGX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 19, 25 | Dhingra Kapil | sell | 25,000 |
| Aug 19, 25 | Viswanadhan Krishnan | sell | 25,000 |
| Aug 19, 25 | Viswanadhan Krishnan | sell | 3,173 |
| Aug 19, 25 | Lubner David Charles | sell | 25,000 |
| Aug 19, 25 | Orwin John A | sell | 15,865 |
| Aug 19, 25 | Orwin John A | sell | 25,000 |
| Aug 19, 25 | Henderson Jane | sell | 25,000 |
| Aug 19, 25 | Bassan Abraham | sell | 25,000 |
| Aug 19, 25 | Huber Reid M | sell | 25,000 |
| Aug 18, 25 | Radhakrishnan Anup | other | 57,345 |
Our CRGX coverage
Recent articles, reports, and earnings notes.
No research on CRGX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CRGX report →Similar companies
Peers in the same neighborhood.